RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder
... known as hyperprolactinemia. Blood levels of
prolactin remain elevated with continued use. Some side ... D2 receptors, RISPERDAL(R) CONSTA(R) elevates
prolactin levels and the elevation persists during chronic ... Risperidone is associated with higher levels of
prolactin elevation than other antipsychotic agents.
...
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
... and similar medicines can raise the blood levels of a hormone called
prolactin and blood levels of
prolactin remain high with continued use. This may result in some side effects ...
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
... causing a condition known as hyperprolactinemia. Blood levels of
prolactin remain elevated with continued use. Some side effects seen with these ... by males; and the inability to achieve an erection. The connection between
prolactin levels and side effects is unknown.
People with narrowing or blockage ...
Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder
... causing a condition known as
hyperprolactinemia. Blood levels of
prolactin remain elevated with
continued use. Some side effects seen with these ... by males; and the inability to achieve an erection. The connection
between
prolactin levels and side effects is unknown.
People with narrowing or blockage of ...
Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
... causing a condition known as
hyperprolactinemia. Blood levels of
prolactin remain elevated with
continued use. Some side effects seen with these ... by males; and the inability to achieve an erection. The connection
between
prolactin levels and side effects is unknown.
High blood sugar and diabetes have ...
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
... In this study, ABILIFY demonstrated no clinically important differences
on
prolactin and the following metabolic parameters: triglyceride, HDL-C,
LDL-C and total cholesterol. All treatment groups showed a reduction in
mean serum
prolactin levels at last visit relative to baseline.
About ABILIFY(R) ...
Vanda Presents Phase III Iloperidone Efficacy Data
... showed similarly low effects on glucose,
cholesterol, triglyceride and
prolactin levels compared to placebo.
Iloperidone also had a similar akathisia ... symptoms (EPS) and
akathisia rates, weight and metabolic parameters, and
prolactin levels.
Unmet Needs in Schizophrenia
Schizophrenia is a chronic, ...
INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
... causing a condition known as hyperprolactinemia. Blood
levels of
prolactin remain elevated with continued use. Some side effects
seen with these ... by males; and the
inability to achieve an erection. The connection between
prolactin levels
and side effects is unknown. High blood sugar and diabetes have ...
FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications
... disease, cerebrovascular diseases, or those predisposed to hypotension.
Other potentially serious adverse events include seizures, elevated
prolactin levels, cognitive and motor impairment, body temperature elevation, and trouble swallowing.
The most common treatment-emergent adverse event ...
FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia
... with any medically important elevations in glucose, triglycerides or cholesterol. Fanapt(TM) was also associated with only modest elevations of
prolactin as compared to larger elevations seen with some other drugs in this class.
Fanapt(TM) has a low incidence of extrapyramidal symptoms (movement ...
Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
... temporally deteriorate or even
rise after discontinuation.
Other potentially serious adverse events include low blood pressure,
seizures, elevated
prolactin levels, elevated liver enzymes,
thromobembolism, neutopenia, sweating, insomnia, tremor, anxiety, nausea,
or vomiting.
Olanzapine should not be ...
Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
... or
completely, if antipsychotic treatment is withdrawn.
Other potentially serious adverse events include low blood pressure,
seizures, elevated
prolactin levels, elevated liver enzymes, cognitive and
motor impairment, body temperature elevation, and trouble swallowing.
The most common ...
Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events
... treatment group had clinically
meaningful increases in metabolic parameters such as blood glucose, body
weight, total cholesterol, triglycerides, or
prolactin elevation(3).
In data presented from three 52-week Phase III trials, comparing a dose
range of iloperidone (4-16 mg/day given BID) to haloperidol ...
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
... or
completely, if antipsychotic treatment is withdrawn.
Other potentially serious adverse events include low blood pressure,
seizures, elevated
prolactin levels, elevated liver enzymes, cognitive and
motor impairment, body temperature elevation, and trouble swallowing.
The most common ...
Vanda Pharmaceuticals Submits Iloperidone New Drug Application
... dopamine and serotonin receptors provides a
favorable safety profile on adverse symptoms, such as weight gain,
extrapyramidal symptoms, akathisia and
prolactin elevation. The NDA
submission also contains pharmacogenetic data aimed to further improve the
benefit/risk profile of iloperidone in the treatment of ...
New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
... in these
populations are unknown. Avoid taking ROZEREM with alcohol. ROZEREM has been associated with decreased testosterone levels and
increased
prolactin levels. Health professionals should be mindful of any
unexplained symptoms possibly associated with such changes in these hormone
levels. ROZEREM ...
ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at
the 2007 International Congress on Schizophrenia Research
... arm combining ACP-103 with
risperidone (2 mg) had significantly lower
prolactin levels after
42 days of treatment compared to patients in the risperidone (6 mg)
plus placebo arm (p=0.0001). The condition of elevated
prolactin is
a commonly observed side effect of antipsychotic therapy and ...
Safety Analyses of Clinical Data for Bifeprunox in Patients with
Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar
to Placebo
... lipoprotein,
similar to placebo.
* Bifeprunox patients experienced decreases in body weight, body mass
index (BMI) and
prolactin and had an extrapyramidal side effects
profile similar to placebo.
-- Weight, BMI and lipids were assessed in patients with acute
...
BioLineRx Presents Data From Successful Phase I Trial for BL-1020
in Schizophrenia at American Psychiatric Association Conference
... of BioLineRx.
The results of this trial were as follows:
1. BL-1020 demonstrated dopamine blockade by dose dependant
elevation in serum
prolactin levels which serves as a surrogate
marker for dopamine antagonism. Dopamine hyperactivity is
implicated in schizophrenia, and is the mechanism of ...
Blood Levels of Paliperidone Extended-Release Tablets are Not
Increased by Common Antidepressant
... in patients
with a history of seizures.
Hyperprolactinemia: As with other drugs that antagonize dopamine
D2 receptors, paliperidone elevates
prolactin levels and the
elevation persists during chronic administration.
Suicide: The possibility of suicide attempt is inherent in
psychotic illnesses and ...
New Study Suggests no Significant Impairment in Middle-of-the-Night
Balance, Mobility or Memory in Older Adults Using Ramelteon
... in
these populations are unknown. Avoid taking ramelteon with alcohol.
Ramelteon has been associated with decreased testosterone levels
and increased
prolactin levels. Health professionals should be
mindful of any unexplained symptoms possibly associated with such
changes in these hormone levels. Ramelteon ...
Investigational Study Evaluates the Effectiveness of Aripiprazole
in Adolescents With Schizophrenia
... 10 mg group; 0.2 kg
(about 0.4 lbs) for the aripiprazole 30 mg group, and -0.8
kilograms (kg), or about 1.8 lbs, for placebo group.
Average
prolactin levels were decreased relative to baseline in
all treatment groups (10 mg aripiprazole, -12 ng/mL; 30 mg
aripiprazole, -17 ng/mL, placebo, -9 ng/mL). ...
Study Demonstrated Rozerem (ramelteon) Does Not Affect
Middle-of-the-Night Balance in Older Adults with Insomnia
... in
these populations are unknown. Avoid taking ROZEREM with alcohol.
ROZEREM has been associated with decreased testosterone levels and
increased
prolactin levels. Health professionals should be mindful
of any unexplained symptoms possibly associated with such changes
in these hormone levels. ROZEREM ...